TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Fullin J; Caiado F; Kovtonyuk LV; Ebert BL; Manz MG; Kurppa KJ; Boettcher S; Stolz SM; Schimmer RR; Mueller J; Klemm N
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Fullin J
Caiado F
Kovtonyuk LV
Ebert BL
Manz MG
Kurppa KJ
Boettcher S
Stolz SM
Schimmer RR
Mueller J
Klemm N
Katso/Avaa
Lataukset: 

ELSEVIER
doi:10.1182/bloodadvances.2021005859
URI
https://doi.org/10.1182/bloodadvances.2021005859
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2022091559191
Kokoelmat